256 related articles for article (PubMed ID: 36377878)
61. Immune B cell responsiveness to single-dose intradermal vaccination against Mycoplasma hyopneumoniae.
Martelli P; Saleri R; Andrani M; Cavalli V; De Angelis E; Ferrari L; Borghetti P
Res Vet Sci; 2021 Dec; 141():66-75. PubMed ID: 34688042
[TBL] [Abstract][Full Text] [Related]
62. Production and characterization of recombinant transmembrane proteins from Mycoplasma hyopneumoniae.
Marchioro SB; Simionatto S; Galli V; Conceição FR; Brum CB; Fisch A; Gomes CK; Dellagostin OA
Vet Microbiol; 2012 Feb; 155(1):44-52. PubMed ID: 21890287
[TBL] [Abstract][Full Text] [Related]
63. A randomized controlled study on the efficacy of a novel combination vaccine against enzootic pneumonia (Mycoplasma hyopneumoniae) and porcine Circovirus type 2 (PCV2) in the presence of strong maternally derived PCV2 immunity in pigs.
Tassis PD; Tsakmakidis I; Papatsiros VG; Koulialis D; Nell T; Brellou G; Tzika ED
BMC Vet Res; 2017 Apr; 13(1):91. PubMed ID: 28388953
[TBL] [Abstract][Full Text] [Related]
64. Th1 and Th17 mucosal immune responses elicited by nasally inoculation in mice with virulence factors of Mycoplasma hyopneumoniae.
Xu L; Hao F; Wang J; Feng Z; Zhang L; Yuan T; Chen R; Zhang Z; Shao G; Xiong Q; Lin J; Xie X; Liu Y
Microb Pathog; 2022 Nov; 172():105779. PubMed ID: 36116609
[TBL] [Abstract][Full Text] [Related]
65. Live attenuated Salmonella enterica serovar Choleraesuis vaccine vector displaying regulated delayed attenuation and regulated delayed antigen synthesis to confer protection against Streptococcus suis in mice.
Ji Z; Shang J; Li Y; Wang S; Shi H
Vaccine; 2015 Sep; 33(38):4858-67. PubMed ID: 26238722
[TBL] [Abstract][Full Text] [Related]
66. The Mycoplasma hyopneumoniae plasma membrane as a vaccine against porcine enzootic pneumonia.
Kobisch M; Quillien L; Tillon JP; Wróblewski H
Ann Inst Pasteur Immunol; 1987; 138(5):693-705. PubMed ID: 3440060
[TBL] [Abstract][Full Text] [Related]
67. Comparative analysis of mucosal immunity to Mycoplasma hyopneumoniae in Jiangquhai porcine lean strain and DLY piglets.
Hua LZ; Wu YZ; Bai FF; William KK; Feng ZX; Liu MJ; Yao JT; Zhang X; Shao GQ
Genet Mol Res; 2014 Jul; 13(3):5199-206. PubMed ID: 25061745
[TBL] [Abstract][Full Text] [Related]
68. A new single-dose bivalent vaccine of porcine circovirus type 2 and Mycoplasma hyopneumoniae elicits protective immunity and improves growth performance under field conditions.
Jeong J; Park C; Choi K; Chae C
Vet Microbiol; 2016 Jan; 182():178-86. PubMed ID: 26711046
[TBL] [Abstract][Full Text] [Related]
69. Porcine antibody profiles of 33 Mycoplasma hyopneumoniae fusion proteins from M. hyopneumoniae natural infection but not vaccination.
Ning Y; Yang Y; Tian Y; Zhang Y; Luo W; Wen Y; Zhou Y; Ding H
Vet Med Sci; 2023 Jan; 9(1):203-216. PubMed ID: 36520664
[TBL] [Abstract][Full Text] [Related]
70. Comparative genomic analyses of Mycoplasma hyopneumoniae pathogenic 168 strain and its high-passaged attenuated strain.
Liu W; Xiao S; Li M; Guo S; Li S; Luo R; Feng Z; Li B; Zhou Z; Shao G; Chen H; Fang L
BMC Genomics; 2013 Feb; 14():80. PubMed ID: 23384176
[TBL] [Abstract][Full Text] [Related]
71. Expression and immunogenicity of Mycoplasma hyopneumoniae heat shock protein antigen P42 by DNA vaccination.
Chen YL; Wang SN; Yang WJ; Chen YJ; Lin HH; Shiuan D
Infect Immun; 2003 Mar; 71(3):1155-60. PubMed ID: 12595427
[TBL] [Abstract][Full Text] [Related]
72. Vaccination of piglets up to 1 week of age with a single-dose Mycoplasma hyopneumoniae vaccine induces protective immunity within 2 weeks against virulent challenge in the presence of maternally derived antibodies.
Wilson S; Van Brussel L; Saunders G; Runnels P; Taylor L; Fredrickson D; Salt J
Clin Vaccine Immunol; 2013 May; 20(5):720-4. PubMed ID: 23486417
[TBL] [Abstract][Full Text] [Related]
73. Interaction between single-dose Mycoplasma hyopneumoniae and porcine reproductive and respiratory syndrome virus vaccines on dually infected pigs.
Park SJ; Seo HW; Park C; Chae C
Res Vet Sci; 2014 Jun; 96(3):516-22. PubMed ID: 24702900
[TBL] [Abstract][Full Text] [Related]
74. Comparison of immune responses to intranasal and intrapulmonary vaccinations with the attenuated Mycoplasma hyopneumoniae 168 strain in pigs.
Li P; Li Y; Shao G; Yu Q; Yang Q
J Vet Med Sci; 2015 May; 77(5):519-25. PubMed ID: 25649413
[TBL] [Abstract][Full Text] [Related]
75. Development and validation of an attenuated Mycoplasma hyopneumoniae aerosol vaccine.
Feng ZX; Wei YN; Li GL; Lu XM; Wan XF; Pharr GT; Wang ZW; Kong M; Gan Y; Bai FF; Liu MJ; Xiong QY; Wu XS; Shao GQ
Vet Microbiol; 2013 Dec; 167(3-4):417-24. PubMed ID: 24035264
[TBL] [Abstract][Full Text] [Related]
76. Antibody responses induced in mice immunized with recombinant adenovectors expressing chimeric proteins of various porcine pathogens.
Roques E; Girard A; Gagnon CA; Archambault D
Vaccine; 2013 May; 31(24):2698-704. PubMed ID: 23583895
[TBL] [Abstract][Full Text] [Related]
77. Immune response of gnotobiotic piglets against Mycoplasma hyopneumoniae.
Muneta Y; Minagawa Y; Shimoji Y; Ogawa Y; Hikono H; Mori Y
J Vet Med Sci; 2008 Oct; 70(10):1065-70. PubMed ID: 18981662
[TBL] [Abstract][Full Text] [Related]
78. C500 variants conveying complete mucosal immunity against fatal infections of pigs with
Liu G; Li C; Liao S; Guo A; Wu B; Chen H
Front Microbiol; 2023; 14():1210358. PubMed ID: 37779705
[No Abstract] [Full Text] [Related]
79. Use of serological and mucosal immune responses to Mycoplasma hyopneumoniae antigens P97R1, P46 and P36 in the diagnosis of infection.
Feng ZX; Bai Y; Yao JT; Pharr GT; Wan XF; Xiao SB; Chi LZ; Gan Y; Wang HY; Wei YN; Liu MJ; Xiong QY; Bai FF; Li B; Wu XS; Shao GQ
Vet J; 2014 Oct; 202(1):128-33. PubMed ID: 25066030
[TBL] [Abstract][Full Text] [Related]
80. Interaction of porcine circovirus type 2 and Mycoplasma hyopneumoniae vaccines on dually infected pigs.
Seo HW; Park SJ; Park C; Chae C
Vaccine; 2014 May; 32(21):2480-6. PubMed ID: 24631087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
